Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Actinium Pharmaceuticals Inc (NY: ATNM ) 1.710 -0.090 (-5.00%) Official Closing Price Updated: 8:00 PM EDT, Nov 1, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 272,349 Open 1.800 Bid (Size) 1.700 (10) Ask (Size) 1.850 (2) Prev. Close 1.800 Today's Range 1.700 - 1.875 52wk Range 1.330 - 10.24 Shares Outstanding 21,331,314 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News 12 Health Care Stocks Moving In Friday's Pre-Market Session October 25, 2024 Via Benzinga Actinium Pharmaceuticals, Inc. (ATNM) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings August 18, 2024 From Bronstein, Gewirtz & Grossman, LLC Via Business Wire Performance YTD -67.86% -67.86% 1 Month -3.93% -3.93% 3 Month -31.05% -31.05% 6 Month -80.66% -80.66% 1 Year -64.08% -64.08% More News Read More Actinium Pharmaceuticals, Inc. (ATNM) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings August 09, 2024 From Bronstein, Gewirtz & Grossman, LLC Via Business Wire ATNM Investors Have Opportunity to Join Actinium Pharmaceuticals, Inc. Fraud Investigation with the Schall Law Firm August 07, 2024 From The Schall Law Firm Via Business Wire ATNM Stock Earnings: Actinium Pharmaceuticals Beats EPS for Q2 2024 August 06, 2024 Via InvestorPlace Why Palantir Technologies Shares Are Trading Higher By Around 10%; Here Are 20 Stocks Moving Premarket August 06, 2024 Via Benzinga S&P 500 Down Over 100 Points; Actinium Pharmaceuticals Shares Plunge August 05, 2024 Via Benzinga Topics Stocks Exposures US Equities Dow Tumbles 950 Points; ISM Services PMI Surges In July August 05, 2024 Via Benzinga Topics Stocks Exposures US Equities Actinium Pharmaceuticals Receives FDA Request For Additional Studies On Leukemia Treatment August 05, 2024 Via Benzinga Exposures Product Safety Nasdaq Tumbles 3%; Tyson Foods Earnings Top Views August 05, 2024 Via Benzinga 3 Under-$10 Biotech Stocks That Could Make You Rich July 11, 2024 Via InvestorPlace 3 Clinical-Stage Biotech Stocks to Buy for Multibagger Returns July 02, 2024 Via InvestorPlace Treatment of Blood Cancers - Biopharma Companies Building out their Pipeline of Solutions June 18, 2024 Via Newsfile Actinium Presents Exciting Data On Leukemic Cell Killing in Preclinical Acute Myeloid Leukemia Models at the 2024 EHA Congress June 18, 2024 Via AB Newswire Acute Myeloid Leukemia Market Size Expected to Reach $2.97 Billion By 2029 as Clinical Trials Increase June 17, 2024 Via FinancialNewsMedia Acute Myeloid Leukemia Market Size Expected to Reach $2.97 Billion By 2029 as Clinical Trials Increase June 17, 2024 From FN Media Group LLC Via GlobeNewswire Acute Myeloid Leukemia is on the Rise as Biotechs Race to Develop Groundbreaking Therapies June 17, 2024 Via FinancialNewsMedia Biopharma Stocks Quest for Solutions for Acute Myeloid Leukemia (AML) June 17, 2024 Via Newsfile Actinium Presents First Ever Data Demonstrating Statistically Significant Anti-Tumor Control and Potent Leukemic Cell Killing with Actimab-A in Combination with Leading Menin Inhibitors in Preclinical Acute Myeloid Leukemia Models at the 2024 EHA Congress June 17, 2024 Via FinancialNewsMedia Actinium Pharmaceuticals (ATNM) Reveals Promising Results from SIERRA Trial at EHA Congress June 17, 2024 Via AB Newswire Topics Intellectual Property Exposures Intellectual Property Under-$10 Picks: 3 Biotech Stocks That Can Double Before the End of 2024 June 10, 2024 Via InvestorPlace Meme Mania Meets Medicine: 3 Biotech Stocks Primed to Soar June 07, 2024 Via InvestorPlace 3 Cheap Biotech Stocks to Buy Now: May 2024 May 14, 2024 Via InvestorPlace Exposures Product Safety Actinium Pharmaceuticals (ATNM) Poised for Breakout as Analysts Project Significant Upside May 09, 2024 Via AB Newswire Actinium Pharmaceuticals (NYSE: ATNM): A Prime Target in a Wave of Radiopharmaceutical Mergers and Acquisitions May 08, 2024 Via AB Newswire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
